Childhood leukaemia: Novartis immunotherapy drug approved after deal with NHS
Sign Up to like & getrecommendations! Published in 2018 at "British Medical Journal"
DOI: 10.1136/bmj.k3799
Abstract: The NHS in England has struck a deal with Novartis that will make an immunotherapy drug for leukaemia available to a small number of children. The agreement, announced on 5 September by Simon Stevens, chief… read more here.
Keywords: novartis immunotherapy; childhood leukaemia; drug approved; leukaemia novartis ... See more keywords